InnoCan Pharma Corporation (CSE:INNO)
Canada · Delayed Price · Currency is CAD 12.55
-0.20 (-1.57%)
Sep 9, 2025, 3:01 PM EDT
InnoCan Pharma Market Cap
InnoCan Pharma has a market cap or net worth of CAD 76.97 million as of September 9, 2025. Its market cap has increased by 9.70% in one year.
Market Cap
76.97M
Enterprise Value
72.37M
Revenue
39.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.55
Market Cap Chart
Since September 25, 2019, InnoCan Pharma's market cap has increased from 1.06M to 76.97M, an increase of 7,144.75%. That is a compound annual growth rate of 105.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 76.97M | 27.74% |
| Dec 31, 2024 | 60.26M | -27.47% |
| Dec 29, 2023 | 83.08M | 54.74% |
| Dec 30, 2022 | 53.69M | -72.99% |
| Dec 31, 2021 | 198.79M | 218.14% |
| Dec 31, 2020 | 62.49M | 171.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.04B |
| Green Thumb Industries | 2.65B |
| Trulieve Cannabis | 2.02B |
| Sienna Senior Living | 1.66B |
| dentalcorp Holdings | 1.64B |
| Cronos Group | 1.33B |
| WELL Health Technologies | 1.20B |
| Extendicare | 1.10B |